18F-fuorodeoxyglucose positron emission tomography in the diagnosis of small pancreatic cancer

World Journal of Gastroenterology

Volumn 17, Issue 2, 2011, Pages 231-235

  Okano, Keiichi ^a   Kakinoki, Keitaro ^a   Akamoto, Shintaro ^a   Hagiike, Masanobu ^a   Usuki, Hisashi ^a   Yamamoto, Yuka ^a   Nishiyama, Yoshihiro ^a   Suzuki, Yasuyuki ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Dual time point evaluation; Ductal carcinoma; Pancreas; Pancreatic cancer; Positron emission tomography

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18; IODINATED CONTRAST MEDIUM; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER SCINTISCANNING; CANCER SIZE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PANCREAS SCINTISCANNING; POSITRON EMISSION TOMOGRAPHY; PROTEIN BLOOD LEVEL; METHODOLOGY; MIDDLE AGED; ONCOLOGY; PANCREAS TUMOR; PATHOLOGY; QUALITY OF LIFE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; QUALITY OF LIFE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79955753956     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i2.231     Document Type: Article

References (22)

1. Matsuno S, Egawa S, Arai K. Trends in treatment for pancreatic cancer. J Hepatobiliary Pancreat Surg 2001; 8: 544-548
2. Yamamoto M, Ohashi O, Saitoh Y. Japan Pancreatic Cancer Registry: current status. Pancreas 1998; 16: 238-242
3. Wakabayashi H, Nishiyama Y, Otani T, Sano T, Yachida S, Okano K, Izuishi K, Suzuki Y. Role of 18F-fuorodeoxyglu-cose positron emissiontomography imaging in surgery for pancreatic cancer. World J Gastroenterol 2008; 14: 64-69
4. Pakzad F, Groves AM, Ell PJ. The role of positron emission tomography in the management of pancreatic cancer. Semin Nucl Med 2006; 36: 248-256
5. Hanbidge AE. Cancer of the pancreas: the best image for early detection--CT, MRI, PET or US? Can J Gastroenterol 2002; 16: 101-105
6. Sato M, Okumura T, Kaito K, Kiyoshima M, Asato Y, Uchiumi K, Iijima H, Hashimoto I, Kaburagi T, Amemiya R. Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer. Ann Nucl Med 2009; 23: 49-57
7. Nishiyama Y, Yamamoto Y, Monden T, Sasakawa Y, Tsutsui K, Wakabayashi H, Ohkawa M. Evaluation of delayed additional FDG PET imaging in patients with pancreatic tumour. Nucl Med Commun 2005; 26: 895-901
8. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Ohtomo K, Kinoshita T, Araki T. Pancreatic ductal adenocarcinoma: preoperative assessment with helical CT versus dynamic MR imaging. Radiology 1997; 202: 655-662
9. Sheridan MB, Ward J, Guthrie JA, Spencer JA, Craven CM, Wilson D, Guillou PJ, Robinson PJ. Dynamic contrast-enhanced MR imaging and dual-phase helical CT in the preoperative assessment of suspectedpancreatic cancer: a comparative study with receiver operating characteristic analysis. AJR Am J Roentgenol 1999; 173: 583-590
10. Legmann P, Vignaux O, Dousset B, Baraza AJ, Palazzo L, Dumontier I, Coste J, Louvel A, Roseau G, Couturier D, Bon-nin A. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol 1998; 170: 1315-1322
11. Tabuchi T, Itoh K, Ohshio G, Kojima N, Maetani Y, Shibata T, Konishi J. Tumor staging of pancreatic adenocarcinoma using early- and late-phase helical CT. AJR Am J Roentgenol 1999; 173: 375-380
12. Kaneko K, Honda H, Hayashi T, Fukuya T, Ro T, Irie H, Ma-suda K. Helical CT evaluation of arterial invasion in pancreatic tumors: comparison with angiography. Abdom Imaging 1997; 22: 204-207
13. DeWitt J, Devereaux B, Chriswell M, McGreevy K, Howard T, Imperiale TF, Ciaccia D, Lane KA, Maglinte D, Kopecky K, LeBlanc J, McHenry L, Madura J, Aisen A, Cramer H, Cum-mings O, Sherman S. Comparison of endoscopic ultrasonog-raphy and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med 2004; 141: 753-763
14. Erturk SM, Ichikawa T, Motosugi U, Sou H, Araki T. Diffusion-weighted MR imaging in the evaluation of pancreatic exocrine function before and after secretin stimulation. Am J Gastroenterol 2006; 101: 133-136
15. Seo S, Doi R, Machimoto T, Kami K, Masui T, Hatano E, Ogawa K, Higashi T, Uemoto S. Contribution of 18F-fluo-rodeoxyglucose positron emission tomography to the diagnosis of early pancreatic carcinoma. J Hepatobiliary Pancreat Surg 2008; 15: 634-639
16. Sperti C, Pasquali C, Chierichetti F, Ferronato A, Decet G, Pedrazzoli S. 18-Fluorodeoxyglucose positron emission tomography in predicting survival of patients with pancreatic carcinoma. J Gastrointest Surg 2003; 7: 953-959; discussion 959-960
17. Maemura K, Takao S, Shinchi H, Noma H, Mataki Y, Kura-hara H, Jinnouchi S, Aikou T. Role of positron emission tomography in decisions on treatment strategies for pancreatic cancer. J Hepatobiliary Pancreat Surg 2006; 13: 435-441
18. Chowdhury P, Rayford PL. Smoking and pancreatic disorders. Eur J Gastroenterol Hepatol 2000; 12: 869-877
19. Lowenfels AB, Maisonneuve P. Epidemiologic and etiologic factors of pancreatic cancer. Hematol Oncol Clin North Am 2002; 16: 1-16
20. Simon B, Printz H. Epidemiological trends in pancreatic neoplasias. Dig Dis 2001; 19: 6-14
21. Ghadirian P, Lynch HT, Krewski D. Epidemiology of pancreatic cancer: an overview. Cancer Detect Prev 2003; 27: 87-93
22. Nakamoto Y, Higashi T, Sakahara H, Tamaki N, Kogire M, Doi R, osotani R, Imamura M, Konishi J. Delayed (18)F-fu-oro-2-deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas. Cancer 2000; 89: 2547-2554a